Patent for Bacteroides xylanisolvens DSM 23964

• The Bacteroides xylanisolvens DSM 23964 strain is characterized by its low pathogenicity and high safety for consumption. It has also been introduced as a microorganism that can be used in food production through fermentation.
  
  
• This strain decomposes dietary fiber to produce short-chain fatty acids (SCFAs) and has been associated with supporting the maintenance of the immune system.
  
  
• The patent for this strain represents a core patent for CorriX, and the CorriX strain is recognized as safe for human consumption and is expected to play a significant role in the research and development of food and functional food products.
  
  
• Furthermore, the CorriX strain serves as a fundamental basis for research into immune functions and anticancer properties, highlighting its potential importance in these fields.